Terms: = Colorectal cancer AND PLCG1, PLC1, 5335, ENSG00000124181, PLC-II, Plcg1, PLCgamma1, PLC148 AND Treatment
4 results:
1. Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic colorectal cancer.
Cruz-Duarte R; Rebelo de Almeida C; Negrão M; Fernandes A; Borralho P; Sobral D; Gallego-Paez LM; Machado D; Gramaça J; Vílchez J; Xavier AT; Ferreira MG; Miranda AR; Mansinho H; Brito MJ; Pacheco TR; Abreu C; Lucia-Costa A; Mansinho A; Fior R; Costa L; Martins M
Clin Cancer Res; 2022 Mar; 28(6):1203-1216. PubMed ID: 34980600
[TBL] [Abstract] [Full Text] [Related]
2. Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment.
Aparicio T; Navazesh A; Boutron I; Bouarioua N; Chosidow D; Mion M; Choudat L; Sobhani I; Mentré F; Soulé JC
Crit Rev Oncol Hematol; 2009 Sep; 71(3):249-57. PubMed ID: 19131256
[TBL] [Abstract] [Full Text] [Related]
3. Validation of in vivo pharmacodynamic activity of a novel PDGF receptor tyrosine kinase inhibitor using immunohistochemistry and quantitative image analysis.
D'Andrea MR; Mei JM; Tuman RW; Galemmo RA; Johnson DL
Mol Cancer Ther; 2005 Aug; 4(8):1198-204. PubMed ID: 16093435
[TBL] [Abstract] [Full Text] [Related]
4. NF-kappaB and Hsp70 are involved in the phospholipase Cgamma1 signaling pathway in colorectal cancer cells.
Li X; Hua L; Deng F; Bai X; Zeng W; Lu D; Su Y; Luo S
Life Sci; 2005 Oct; 77(22):2794-803. PubMed ID: 15996687
[TBL] [Abstract] [Full Text] [Related]
